List of Tables
    Table 1. Key Players of Human Vaccines Administered Orally in Global Market
    Table 2. Top Human Vaccines Administered Orally Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Human Vaccines Administered Orally Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Human Vaccines Administered Orally Revenue Share by Companies, 2017-2022
    Table 5. Global Human Vaccines Administered Orally Sales by Companies, (K Units), 2017-2022
    Table 6. Global Human Vaccines Administered Orally Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Human Vaccines Administered Orally Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Human Vaccines Administered Orally Product Type
    Table 9. List of Global Tier 1 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
    Table 15. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
    Table 16. By Application – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
    Table 20. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
    Table 21. By Region – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
    Table 25. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
    Table 26. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 29. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 38. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 41. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2023-2028
    Table 46. Merck Corporate Summary
    Table 47. Merck Human Vaccines Administered Orally Product Offerings
    Table 48. Merck Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. GSK Corporate Summary
    Table 50. GSK Human Vaccines Administered Orally Product Offerings
    Table 51. GSK Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Sanofi Corporate Summary
    Table 53. Sanofi Human Vaccines Administered Orally Product Offerings
    Table 54. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. Lanzhou Institute Corporate Summary
    Table 56. Lanzhou Institute Human Vaccines Administered Orally Product Offerings
    Table 57. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. Serum Institute Corporate Summary
    Table 59. Serum Institute Human Vaccines Administered Orally Product Offerings
    Table 60. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Valneva Corporate Summary
    Table 62. Valneva Human Vaccines Administered Orally Product Offerings
    Table 63. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. Shanghai United Cell Corporate Summary
    Table 65. Shanghai United Cell Human Vaccines Administered Orally Product Offerings
    Table 66. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. Bibcol Corporate Summary
    Table 68. Bibcol Human Vaccines Administered Orally Product Offerings
    Table 69. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 70. PaxVax Corporate Summary
    Table 71. PaxVax Human Vaccines Administered Orally Product Offerings
    Table 72. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 73. Vabiotech Corporate Summary
    Table 74. Vabiotech Human Vaccines Administered Orally Product Offerings
    Table 75. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 76. Tiantan Biological Corporate Summary
    Table 77. Tiantan Biological Human Vaccines Administered Orally Product Offerings
    Table 78. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 79. EuBiologics Corporate Summary
    Table 80. EuBiologics Human Vaccines Administered Orally Product Offerings
    Table 81. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 82. Panacea Biotec Ltd Corporate Summary
    Table 83. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offerings
    Table 84. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 85. Bio-Med Corporate Summary
    Table 86. Bio-Med Human Vaccines Administered Orally Product Offerings
    Table 87. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 88. Halfkin Bio-Pharmaceuticals Corporate Summary
    Table 89. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offerings
    Table 90. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 91. Human Vaccines Administered Orally Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 92. Global Human Vaccines Administered Orally Capacity Market Share of Key Manufacturers, 2020-2022
    Table 93. Global Human Vaccines Administered Orally Production by Region, 2017-2022 (K Units)
    Table 94. Global Human Vaccines Administered Orally Production by Region, 2023-2028 (K Units)
    Table 95. Human Vaccines Administered Orally Market Opportunities & Trends in Global Market
    Table 96. Human Vaccines Administered Orally Market Drivers in Global Market
    Table 97. Human Vaccines Administered Orally Market Restraints in Global Market
    Table 98. Human Vaccines Administered Orally Raw Materials
    Table 99. Human Vaccines Administered Orally Raw Materials Suppliers in Global Market
    Table 100. Typical Human Vaccines Administered Orally Downstream
    Table 101. Human Vaccines Administered Orally Downstream Clients in Global Market
    Table 102. Human Vaccines Administered Orally Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Human Vaccines Administered Orally Segment by Type
    Figure 2. Human Vaccines Administered Orally Segment by Application
    Figure 3. Global Human Vaccines Administered Orally Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Human Vaccines Administered Orally Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Human Vaccines Administered Orally Revenue, 2017-2028 (US$, Mn)
    Figure 7. Human Vaccines Administered Orally Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Human Vaccines Administered Orally Revenue in 2021
    Figure 9. By Type - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 10. By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Human Vaccines Administered Orally Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 13. By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Human Vaccines Administered Orally Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 16. By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 19. US Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 24. Germany Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 25. France Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 33. China Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 37. India Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 40. Brazil Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Human Vaccines Administered Orally Sales Market Share, 2017-2028
    Figure 44. Turkey Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Human Vaccines Administered Orally Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Human Vaccines Administered Orally by Region, 2021 VS 2028
    Figure 50. Human Vaccines Administered Orally Industry Value Chain
    Figure 51. Marketing Channels